1110 Federal Register / Vol. 89, No. 6 / Tuesday, January 9, 2024 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research; Special 

Grants Review Committee. 

Date: February 22–23, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research, 6701 Democracy 

Blvd., Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Thomas John O’Farrell, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, National Institute of Dental & 

Craniofacial Research, 6701 Democracy 

Blvd., Bethesda, MD 20892, 301–402–8559, 

tom.ofarrell@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: January 4, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00249 Filed 1–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation for Public Comments on 

Questions From the Task Force on 

Maternal Mental Health 

AGENCY: Office on Women’s Health, 

Office of the Assistant Secretary for 

Health, Office of the Secretary; 

Substance Abuse and Mental Health 

Services Administration (SAMHSA), 

U.S. Department of Health and Human 

Services (HHS) 

ACTION: Notice of request for 

information 

SUMMARY: The Task Force on Maternal 

Mental Health (Task Force), which is 

being implemented as a subcommittee 

of the SAMHSA Advisory Committee 

for Women’s Services (ACWS), solicits 

public comments on a set of questions 

concerning the context, policies, 

effectiveness, promising practices, and 

limitations and gaps related to 

prevention and treatment of maternal 

mental health conditions and substance 

use disorders (inclusive of alcohol use/ 

misuse) and its complications. The Task 

Force is required to solicit public 

comments, as appropriate, from 

stakeholders for the purposes of 

developing a report that analyzes and 

evaluates the state of maternal mental 

health programs at the Federal level and 

identifies best practices with respect to 

maternal mental health and substance 

use disorders as well as a national 

strategy for improving maternal mental 

health. The taskforce will be 

highlighting recommendations that fall 

within the pregnancy and postpartum 

(up to 1 year after birth) periods for 

individuals with or at risk for mental 

health and substance use conditions. 

DATES: Electronic or written/paper 

comments will be accepted through 

midnight eastern standard time (EST) 

January 31, 2024. 

ADDRESSES: The set of questions is 

available in the SUPPLEMENTARY

INFORMATION section below. Public 

comments can be submitted in the 

following ways: 

• Electronic submissions can be filed 

online at http://www.regulations.gov by 

following the ‘‘Instructions for Public 

Comments’’ section below. Comments 

submitted electronically, including 

attachments, will be posted to the 

docket unchanged. Evidence and 

information supporting your comment 

can be submitted as attachments. Please 

provide your contact information or 

organization name on the web-based 

form for follow up by the Task Force. 

• If you prefer to comment on paper, 

mail your comment to the following 

address: 5600 Fishers Lane, Suite 

18E01, Rockville, MD 20857. For mailed 

submissions, OWH/SAMHSA will post 

your comment, as well as any 

attachments, to http://

www.regulations.gov. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket ID into the ‘‘Search’’ box and 

follow the prompts. 

FOR FURTHER INFORMATION CONTACT: 

Valerie Kolick, Designated Federal 

Officer, Advisory Committee for 

Women’s Services, U.S. Department of 

Health and Human Services, Substance 

Abuse and Mental Health Services 

Administration, 5600 Fishers Lane, 

Suite 18E01, Rockville, MD 20857. 

Phone: 240–276–1738 or Email: 

valerie.kolick@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: Section 

1113 of the Consolidated 

Appropriations Act, 2023 (Pub. L. 117– 

328) requires the HHS Secretary to 

establish a Task Force on Maternal 

Mental Health or incorporate the duties, 

public meetings, and reports specified 

into existing relevant Federal 

committees or working groups. The 

Task Force consists of representatives of 

specific federal agencies and nonfederal individuals and entities who 

represent diverse disciplines and views. 

The Task Force will evaluate and make 

recommendations to the ACWS for 

further deliberation regarding 

improvements and coordination for 

Federal activities that address maternal 

mental health and co-occurring 

substance use disorders. The ACWS will 

make final recommendations to the 

Secretary of Health and Human Services 

and to Congress. 

The Task Force invites members of 

the public to comment on any issues or 

concerns they believe are relevant or 

appropriate to the state of maternal 

mental health programs at the Federal 

level, and identification of best practices 

with respect to maternal mental health 

and substance use. Specifically, the 

Task Force requests public comment on 

the following questions: 

1. Data, Research and Quality 

Improvement: 

• What are the priority outcomes for 

pregnant and postpartum individuals 

with substance use disorder and/or 

mental health conditions? 

• How would you define quality care 

for pregnant and postpartum 

individuals with substance use 

disorders and/or mental health 

conditions? 

• What are the priority research 

questions and gaps related to maternal 

substance use disorder and/or mental 

health conditions that must be 

addressed to improve services and 

outcomes for individuals while 

pregnant and postpartum? 

2. Prevention, Screening and 

Diagnosis: 

• What is lacking and what is 

working to support maternal emotional 

health, and substance use and wellbeing during pregnancy and after? 

• What steps should be taken to 

ensure that approaches to detecting 

maternal emotional health issues and 

substance use challenges are culturally 

appropriate? 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 6 / Tuesday, January 9, 2024 / Notices 1111 

• What can be done to help pregnant 

and postpartum individuals feel more 

comfortable to open up about how they 

are feeling? Who, where, and how might 

pregnant and postpartum individuals 

feel safest about disclosing their 

experience? 

3. Evidence-based Intervention and 

Treatment: 

• What are key evidence-based 

intervention and treatment models that 

should be broadly implemented to 

address maternal mental health and 

substance use? 

i. Do providers have the training and 

resources to appropriately provide 

evidenced-based intervention and 

treatment or referral? 

ii. Are community-based resources 

being utilized to bridge the gap in 

education, evidence-based screening, 

and treatment or referral? If not, what 

are the challenges of incorporating 

culturally competent community-based 

health care workers? 

• What are the barriers/gaps to 

evidence-based intervention for 

maternal mental health and substance 

use among reproductive age 

individuals? How do access and 

engagement differ between people who 

have already received mental health 

and/or substance use treatment prior to 

pregnancy versus those who never 

have? 

• Are underserved populations 

represented in the research and 

subsequent guidelines developed from 

the research for screening and 

treatment? What evidence is still needed 

to inform guidelines for screening and 

treatment, including for 

underrepresented, underserved 

populations? 

i. Underserved populations may 

include Black, Latino, and Indigenous 

and American Indian/Alaska Native 

persons, Asian Americans and Pacific 

Islanders and other persons of color; 

members of religious minorities; 

lesbian, gay, bisexual, transgender, 

queer, and intersex (LGBTQI+) persons; 

persons with disabilities; persons who 

live in rural areas; and persons 

otherwise adversely affected by 

persistent poverty or inequality. 

4. Evidence-Based Community 

Practices: 

• What are the most pressing needs 

related to maternal mental health and 

maternal substance use in your 

community? For the purposes of this 

question, please define ‘‘community’’ 

however it most resonates with you 

(e.g., geography, race, ethnicity, sexual 

orientation, and gender identity, 

disability status, American Indian/ 

Alaska Native status, veteran status, 

etc.) 

• What strategies have been the most 

successful, transformative, and/or 

sustainable in addressing maternal 

mental health and maternal substance 

use needs in your community? What 

strategies have been the least successful, 

transformative, and/or sustainable, and 

why? 

• What innovations are needed to 

better address maternal mental health 

and substance use needs in your 

community (i.e., how can communitybased organizations and entrepreneurs 

partner to address gaps and provide 

support for areas of identified need)? 

5. Communications and Community 

Engagement: 

• What do ideal services and 

resources look like for a pregnant or 

postpartum individual in your 

community? And what are barriers to 

access to these services? 

• What steps should be taken to 

ensure that approaches to detecting 

maternal emotional health issues and 

substance use challenges are culturally 

appropriate? 

• What can be done to help mothers 

and pregnant and postpartum people 

feel more comfortable to open up about 

how they are feeling? Who, where, and 

how might mothers and pregnant and 

postpartum people feel safest about 

disclosing their experience? 

How to submit a response: All 

submissions must be submitted in the 

Docket ID HHS- for ‘‘Solicitation for 

Public Comments on Questions from the 

Task Force on Maternal Mental Health.’’ 

Comments are encouraged from the 

public and will be accepted through 

January 31, 2024. The https://

www.regulations.gov electronic filing 

system will accept electronic comments 

until midnight eastern time at the end 

of January 31, 2024. Comments received 

by mail/courier will be considered if 

they are postmarked or the delivery 

service acceptance receipt date is on or 

before that date. Written comments via 

mail will be uploaded into https://

www.regulations.gov and are under the 

same limitations as for those directly 

submitted electronically into https://

www.regulations.gov: 5,000 character 

limit for text box, and maximum 

number (10) of attached files and 

maximum size (10 MB) of each attached 

file. 

This RFI is for informational and 

planning purposes only and is not a 

solicitation for applications or an 

obligation on the part of the 

Government to provide support for any 

ideas identified in response to it. Please 

note that the Government will not pay 

for the preparation of any information 

submitted or for use of that information. 

Alicia Broadus, 

Public Health Advisor. 

[FR Doc. 2023–28890 Filed 1–8–24; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2023–0674] 

National Maritime Security Advisory 

Committee; February 2024 Meeting 

AGENCY: United States Coast Guard 

(USCG), Department of Homeland 

Security (DHS). 

ACTION: Notice of open Federal advisory 

committee meeting. 

SUMMARY: The National Maritime 

Security Advisory Committee 

(Committee) will conduct a series of 

meetings over three days in conjunction 

with the 11th Annual Maritime Security 

East Conference in Arlington, VA to 

discuss the Committee’s open taskings 

concerning NVIC 03–03 updates, Active 

Shooter/Active Threat in the Maritime 

Environment, and Unmanned Systems 

in the Maritime Environment. All 

meetings will be open to the public and 

will not require registration to the 

Conference. 

DATES: 

Meetings: The Committee will meet 

on Monday, February 5, 2024, from 1:40 

p.m. until 3:40 p.m. Eastern Standard 

Time (EST), Tuesday, February 6, 2024, 

from 10 a.m. until noon (EST), and on 

Wednesday, February 7, 2024, from 

10:15 a.m. until 12:15 p.m. (EST). Please 

note these meetings may close early if 

the Committee has completed its 

business. 

Comments and supporting 

documentation: To ensure your 

comments are received by Committee 

members before the meetings, submit 

your written comments no later than 

February 1, 2024. 

ADDRESSES: The meetings will be held 

in the Tidewater II conference room at 

the Hyatt Regency Crystal City, 2799 

Richmond Highway, Arlington, VA 

22202, website Crystal City, VA Hotels 

Near DCA | Hyatt Regency Crystal City 

at Reagan National Airport. The 

meetings will also be held virtually. To 

join the virtual meetings or to request 

special accommodations, contact the 

individual listed in the FOR FURTHER

INFORMATION CONTACT section no later 

than 1 p.m. EST on February 1, 2024, to 


khammond on DSKJM1Z7X2PROD with NOTICES